- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04403425
Tissue Perfusion During Emergency Laparotomy
Correlation of Central and Peripheral Measures of Tissue Perfusion During Emergency Laparotomy - a Pilot Study
Study Overview
Status
Detailed Description
Early detection and treatment of insufficient tissue perfusion and oxygenation is the main purpose of perioperative haemodynamic monitoring and management. Hypovolemia, septicaemia, and low flow states affecting central and peripheral perfusion are frequent in patients undergoing emergency laparotomy.
This study aims to assess the effects of Noradrenaline (NA) on cardiac preload, and tissue perfusion in patients undergoing emergency laparotomy, to investigate potential macro/microcirculatory uncoupling.
A single-centre, prospective interventional non-blinded single-arm study at the Department of Anaesthesiology and Intensive care Unit, Copenhagen University Hospital Hvidovre, Denmark. We will include patients undergoing emergency laparotomy. The study start is January 2021. After informed consent, patients will be included if they have an intraoperative need for Noradrenaline infusion >0.1 mcg/kg/min to maintain MAP ≥65 mmHg after resuscitation with a goal-directed fluid therapy algorithm. 20 patients will be included.
Intervention: At a steady state (MAP ≥65 mmHg) during the surgical procedure, we will reduce NA to investigate whether patients will be preload responsive while maintaining MAP > 50 mmHg and limiting stroke volume reduction to no more than 30%. After a subsequent fluid challenge, we will increase the dose of NA to re-establish a MAP ≥65 mmHg. In addition, peripheral and central perfusion indices, including gut perfusion, will be measured.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Hvidovre, Denmark
- Recruiting
- Copenhagen University Hospital Hvidovre
-
Contact:
- Mirjana Cihoric, MD
- Phone Number: +4522475828
- Email: mirjana.cihoric.03@regionh.dk
-
Contact:
- Nicolai Bang Foss, MD, DMSc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Adults (18 years or over) undergoing emergency laparotomy/laparoscopy for following abdominal pathology:
- Perforated viscus
- Intestinal obstruction
- Emergency re-operations after elective surgery owing to paralytic/obstructive ileus, anastomotic leakage
- Provided verbal and written informed consent
- Must speak and understand the Danish language
- Intraoperative indication for Norepinephrine infusion
Exclusion Criteria:
- Appendectomies, cholecystectomies, negative diagnostic laparoscopies/laparotomies, herniotomies without bowel resections, sub-acute internal hernias after gastric bypass surgery, sub-acute surgery for inflammatory bowel diseases.
- Reoperation owing to fascial separation with no other abdominal pathology identified and sub-acute colorectal cancer-surgery will be excluded from the cohort. Sub-acute surgery is defined as surgery planned within 48 hours.
- Intestinal Ischemia
- intraabdominal bleeding
- Traumas, gynecological, urogenital and other vascular pathology, pregnant patients.
- Dementia and/or cognitive dysfunction (diagnosed). If the patient is not awake, alert, and oriented, times three (to person, place, and time), this also qualifies as an exclusion criterion.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Emergency laparotomy, obstruction
Patients undergoing emergency laparotomy for intestinal obstruction in need of intraoperative Noradrenaline infusion to maintain predefined normotension.
|
Emergency laparotomy, perforation
Patients undergoing emergency laparotomy for perforated ventricle or intestine in need of intraoperative Noradrenaline infusion to maintain predefined normotension.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Preload dependency
Time Frame: intraoperatively (during general anesthesia)
|
the incidence of preload dependency defined as stroke volume increase of >10% during fluid challenge after reduction of Noradrenaline.
|
intraoperatively (during general anesthesia)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Tissue perfusion and fluid status
Time Frame: intraoperatively (during general anesthesia)
|
changes in perfusion indices (delta values) after NA reduction, one fluid bolus, and subsequent restoration of blood pressure with Noradrenaline.
|
intraoperatively (during general anesthesia)
|
Tissue perfusion
Time Frame: intraoperatively (during general anesthesia)
|
Other endpoints of interest are the correlation between gut perfusion and indices of central and peripheral perfusion (urethral, cerebral, tissue).
|
intraoperatively (during general anesthesia)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-19069841
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intestinal Obstruction
-
Jinling Hospital, ChinaCompletedChronic Intestinal Pseudo ObstructionChina
-
MovetisCompletedChronic Intestinal Pseudo-ObstructionUnited Kingdom
-
University of NottinghamNorthern Care Alliance NHS Foundation Trust; Cambridge University Hospitals... and other collaboratorsRecruiting
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldRecruitingIleus | Small Bowel Obstruction | Intestinal FailureUnited Kingdom
-
Alfasigma S.p.A.Active, not recruitingChronic Intestinal Pseudo-obstructionBelgium, Italy, Spain
-
Roswell Park Cancer InstituteTerminatedMalignant Bowel ObstructionUnited States
-
Yale UniversityTerminatedSmall Bowel ObstructionUnited States
-
Shanghai 10th People's HospitalCompletedFecal Microbiota Transplantation | Intestinal Pseudo-ObstructionChina
-
Danish Small Bowel Obstruction CollaborativeActive, not recruiting
-
Helsinki University Central HospitalCompleted